139 related articles for article (PubMed ID: 9071070)
1. Microsatellite instability in Epstein-Barr virus associated with nasopharyngeal carcinoma.
Tanunyutthawongese C; Sriuranpong V; Kerekhanjanarong V; Changchup B; Yenrudi S; Supiyaphun P; Voravud N; Mutirangura A
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S71-7. PubMed ID: 9071070
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity for chromosome 11 in Epstein-Barr-virus associated nasopharyngeal carcinoma.
Mutirangura A; Tanunyutthawongese C; Kerekhanjanarong V; Sriuranpong V; Pornthanakasem W; Yenrudi S; Supiyaphun P; Voravud N
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S65-70. PubMed ID: 9071069
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
4. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
Sun N; Chen X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and nasopharyngeal carcinoma: bringing molecular genetics strategies to head and neck oncology.
Freeman JL; McIvor NP; Feinmesser R; Cheung RK; Dosch HM
J Otolaryngol; 1994 Apr; 23(2):130-4. PubMed ID: 8028071
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
Tsai ST; Jin YT; Mann RB; Ambinder RF
Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.
Mutirangura A; Tanunyutthawongese C; Pornthanakasem W; Kerekhanjanarong V; Sriuranpong V; Yenrudi S; Supiyaphun P; Voravud N
Br J Cancer; 1997; 76(6):770-6. PubMed ID: 9310244
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and nasopharyngeal cancer.
Meisler AI
N Engl J Med; 1996 Jan; 334(2):122; author reply 122-3. PubMed ID: 8531952
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
Rathaur RG; Chitale AR; Banerjee K
Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
12. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
14. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
Hao SP; Tsang NM; Chang KP
Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of Epstein-Barr virus A73 gene polymorphisms to susceptibility to nasopharyngeal carcinoma].
Zhang LL; Li DJ; Li ZH; Zhang XS; Zhang RH; Yu XJ; Chen LZ; Feng QS; Zeng YX; Jia WH
Ai Zheng; 2007 Oct; 26(10):1047-51. PubMed ID: 17927871
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
18. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
19. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
Chua HH; Yeh TH; Wang YP; Sheen TS; Shew JY; Huang YT; Tsai CH
Head Neck; 2008 Dec; 30(12):1575-85. PubMed ID: 18798303
[TBL] [Abstract][Full Text] [Related]
20. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
Lin CT; Chen W; Hsu MM; Dee AN
Lab Invest; 1997 Jun; 76(6):793-8. PubMed ID: 9194855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
